title: [Bulletin INFOVAC-France].
authors: R
authors: R
authors: Cohen
authors: P
authors: P
authors: Bakhache
authors: P
authors: P
authors: Bégué
authors: P
authors: P
authors: Besse
authors: M-A
authors: MA
authors: Dommergues
authors: V
authors: V
authors: Dufour
authors: D
authors: D
authors: Floret
authors: J-M
authors: JM
authors: Garnier
authors: J
authors: J
authors: Gaudelus
authors: E
authors: E
authors: Grimprel
authors: N
authors: N
authors: Guérin
authors: I
authors: I
authors: Hau
authors: D
authors: D
authors: Pinquier
authors: P
authors: P
authors: Reinert
authors: O
authors: O
authors: Romain
authors: G
authors: G
authors: Thiebault
authors: F
authors: F
authors: Vié le Sage
authors: B
authors: B
authors: Virey
authors: C
authors: C
authors: Weil-Olivier
authors: C-A
authors: CA
authors: Siegrist
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D052685:Alphapapillomavirus; D035881:Compensation and Redress; D005602:France; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000009:adverse effects* / Q000276:immunology; D010506:Periodicals as Topic; D011129:Polyradiculoneuropathy / Q000139:chemically induced*
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines